Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAIREA Regulatory News (AIEA)

Share Price Information for AIREA (AIEA)

Share Price is delayed by 15 minutes
Get Live Data
28.00    0.00 (0.00%)
Bid:
27.00
Ask:
29.00
Spread: 2.00 (7.407%)
Market Cap: £11.14m
AIEA Live PriceLast checked at - London Stock Exchange

Intraday AIREA Share Chart

Director / PDMR Dealing

16 Jun 2026 09:49

RNS Number : 4844I
Airea PLC
16 June 2026
 

 

16 June 2026

AIREA plc

 

("AIREA", the "Group" or the "Company")

 

Director / PDMR Dealing

 

AIREA plc (AIM: AIEA) announces that, following payment of the Company's dividend on 20 May 2026 (as approved by shareholders at the Company's Annual General Meeting on 6 May 2026), Tanya Ashton, Independent Non-Executive Director, purchased 1,347 ordinary shares of 25 pence each in the capital of the Company ("Ordinary Shares") on 11 June 2026 through the Company's dividend reinvestment plan. This transaction was effected at a reference price of 28 pence per Ordinary Share.

Further details are set out in the notification of dealing form below.

Following the transaction, Tanya Ashton's total interest in the Company is in 39,719 Ordinary Shares, representing 0.096% of the ordinary issued share capital in the Company.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCAs") with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tanya Ashton

2

Reason for the notification

a)

Position/status

Independent Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

AIREA plc

b)

LEI

213800FNWL76NCLZU343 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 25 pence each

Identification code

GB0008123027

b)

Nature of the transaction

Acquisition of Ordinary Shares through a Dividend Reinvestment Plan

c)

 

Price(s) and volume(s)

 

Price

Volume

£0.28

1,347

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A - single transaction.

e)

Date of the transaction

11 June 2026

f)

Place of the transaction

London Stock Exchange, AIMX

 

 

For further information please contact:

 

AIREA plc

Médéric Payne, Chief Executive Officer

Conleth Campbell, Chief Financial Officer

Tel: +44 (0) 192 426 6561

Singer Capital Markets(Nominated Adviser and Sole Broker)

Peter Steel / Anastassiya Eley

Tel: +44 (0) 20 7496 3000

Northstar Communications(Financial media and PR)

Sarah Hollins

Tel: +44 (0) 7764 947137

 

Notes to Editors

 

AIREA plc is a UK design-led specialist flooring company, supplying both UK and international markets. Since 2007, the Group has been focused solely on floor coverings and enjoys a strong and growing brand position within the commercial flooring market.

 

The Group's core brand Burmatex® is one of the UK's leading designers and manufacturers of commercial carpet tiles and planks. Burmatex® focuses on the design and creation of sustainable innovative flooring solutions to meet the needs of architects, specifiers and contractors with a continuously developing range to suit the education, leisure, commercial, hospitality and public sectors. The brand was acquired by AIREA in 1984.

 

The Group was admitted to trading on AIM of the London Stock Exchange on 12 December 2007.

 

For further information, please visit: https://aireaplc.com/.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKABQFBKKFAD
Date   Source Headline
16th Jun 20269:49 amRNSDirector / PDMR Dealing
8th Jun 20265:10 pmRNSExercise of Options / PDMR notification
6th May 20263:06 pmRNSResult of AGM
6th May 20262:00 pmRNSAGM Statement
20th Apr 202612:23 pmRNSDirector/PDMR Dealing
26th Mar 20267:00 amRNSFinal Results for the year ended 31 December 2025
9th Mar 20267:00 amRNSNotice of Results
11th Feb 20268:52 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSPre-close Trading Update
1st Oct 20259:08 amRNSHolding(s) in Company
30th Sep 20254:12 pmRNSDivestment of Investment Property
30th Sep 20257:00 amRNSInterim Results
29th Jul 20257:00 amRNSPre-close Trading Update and Notice of Results
7th May 20253:06 pmRNSResult of AGM
7th May 202512:01 pmRNSDirector/PDMR Dealing
7th May 202512:00 pmRNSAGM Statement
28th Mar 20257:00 amRNSDirector/PDMR Dealings
27th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
10th Mar 20257:00 amRNSNotice of Results
30th Jan 20257:00 amRNS-ROpening of Dubai Showroom
23rd Jan 202510:40 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSPre-close Trading Update
26th Sep 202411:43 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSInterim Results
6th Aug 20247:00 amRNSPre-close Trading Update and Notice of Results
28th Jun 20247:00 amRNSLong Term Incentive Plan Awards
8th May 20243:07 pmRNSResult of AGM
8th May 202412:00 pmRNSAGM Statement
26th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
11th Mar 20247:00 amRNSNotice of Results
24th Jan 20247:00 amRNSTrading update and £5.0m investment in facility
3rd Oct 20237:00 amRNSAppointment of Chief Financial Officer
28th Jul 202310:30 amRNSHolding(s) in Company
27th Jul 20237:00 amRNSInterim Results
4th Jul 20233:00 pmRNSDirectorate Change
22nd Jun 20237:00 amRNSHolding(s) in Company
10th May 20232:56 pmRNSResult of AGM
10th May 202312:00 pmRNSAGM Statement
10th May 20237:00 amRNSAppointment of Independent Non-Executive Director
13th Apr 20233:42 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSFinal Results for the year ended 31 December 2022
16th Dec 20227:00 amRNSLong Term Incentive Plan Awards
7th Dec 20224:59 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSAppointment of Chief Executive
29th Jul 20221:54 pmRNSHolding(s) in Company
28th Jul 20227:00 amRNSInterim Report
24th May 20223:02 pmRNSRe Dividend
17th May 20224:01 pmRNSResult of AGM
12th Apr 20227:00 amRNSFinal Results for the year ended 31 December 2021
29th Mar 20224:40 pmRNSDeath of a Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.